Impact of prophylactic skin toxicity management on treatment continuity and clinical outcomes in EGFR-mutant non-small cell lung cancer treated with osimertinib: a 7-year real-world retrospective cohort study

Supportive Care in Cancer 2026

View at publisher
Authors: Thanawat Khongyot, M. N. B. Melgo, R. Nurat, M. Chanthachot, R. Kochasen, W. Homkaen, R. Z. Longakit, C. Sunphakorn, N. Detkaew, Mohitosh Biswas, P. Srikaew, S. Dejrattanawichai
+1 more T. Majam
DOI: 10.1007/s00520-026-10896-4
Cited by: 1
References: 13

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Colorectal Cancer Treatments and Studies Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Supportive Care in Cancer
Publisher
Springer Science and Business Media LLC
Volume
34
Issue
7
Publication date
13 June 2026
Language
EN